alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 80, Number 41 (Tuesday, March 3, 2015)]
[Notices]
[Pages 11441-11442]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-04330]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices (ACIP)

    Correction: This notice was published in the Federal Register on 
January 30, 2015, Volume 80, Number 20, Page 5116-5117. Due to 
inclement weather in the Atlanta, Georgia area, the first day of the 
meeting scheduled for February 25 and 26, 2015 was not held. The second 
day of the meeting will take place as follows:

[[Page 11442]]

    Times and Dates: 10:00 a.m.-2:00 p.m., February 26, 2015.
    The meeting will be webcast live via the World Wide Web; for 
instructions and more information on ACIP please visit the ACIP Web 
site: http://www.cdc.gov/vaccines/acip/index.html.
    Matters To Be Discussed: The shortened agenda will include 
discussions and votes on: Influenza LAIV use, serogroup B meningococcal 
(MenB) vaccines use in high risk groups, including outbreaks, and the 
use of 9vHPV vaccine.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Stephanie B. Thomas, National 
Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton 
Road NE., MS-A27, Atlanta, Georgia 30333, telephone: (404) 639-8836; 
Email <a href="/cdn-cgi/l/email-protection#81c0c2c8d1c1c2c5c2afc6ced7"><span class="__cf_email__" data-cfemail="3b7a78726b7b787f78157c746d">[email protected]</span></a>.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the Centers for Disease Control and Prevention and the Agency for 
Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-04330 Filed 3-2-15; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
_______________________________________ __ Michigan Supreme Court 

# Order
Lansing, Michigan

December 15, 2005 Clifford W. Taylor, Chief Justice 128816 Michael F. Cavanagh Elizabeth A. Weaver Marilyn Kelly Maura D. Corrigan PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee, Robert P. Young, Jr. Stephen J. Markman, Justices

v SC: 128816 COA: 251720 Macomb CC: 03-000570-FH JOEY DEAN JARVIS, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, th e application for leave to appeal the Ap ril 12, 2005 judgment of the Court of Appeals is cons idered, and it is DENIED, because we are not persuaded that the questions presented should be reviewed by this Court.

K ELLY , J., would reverse and rema nd this case to the circuit court for a new trial.

s1208 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

December 15, 2005

Clerk
EXHIBIT 10.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the incorporation by reference in the Registration
Statements on Form S-8 (No. 33-80797, No. 33-90616, No. 333-06390, No.
333-06862, No. 333-07226 and No. 333-12732) of STMicroelectronics N.V. of our
reports dated February 1, 2001 relating to the financial statements and
financial statement schedule, which appear in this Form 20-F.





PRICEWATERHOUSECOOPERS N.V.
Amsterdam, The Netherlands
May 14, 2001
REF ID:A71934 ~ T 

/ 

/ UNIVERSITY OF ILLINOIS 

DEPARTMENT OF MATHEMATICS 

URBANA ILLINOIS 

National Security Agency 

Washington 25, D. c. 

May 18, 1953 

Att•n W. F. Friedman 

Dear Mr. Friedman: 

Thank you tor your letter of May 14 and for the notice 

or the meeting on June 11 and 12. I am completely satisfied both 

with the notice and with the agenda. 

As far as the SCAMP situation is concerned there ar~ 

many reasons, most of which have undoubtedly occurred to you, why it would be unfortunate to shift the program to Cal Tech tor this 

summer. Not the least of these is the fact that a number of 

prospective participants, including me, have made housing arrangements with the idea that the program would be at the INA. I have 

already paid a month's rent and am completely committed to a house 

which is convenient to the INA but which would involve excessive 

commuting to get to Pasadena. Others may have done the same sort 

of thing. In particular, I believe Gordon Pall has ma.de a commitment. Thus a transfer of locale should be considered only as a 

desperate last resort. 

~I expect to be in Washington on May 27, 28 and 29. On 

the 28th I shall be at meetings of the National Research Council 

Division of Mathematics. On either or both of the other two days I shall be free to work on matters connected with SCAMP or the 

Advisory Board. I need no travel orders for this trip in Me.y since the National Research Council will pay my transportation. ,...._ 

( In having travel orders prepared for the June 11 and 12 

} meeting I hope the example can be followed which permitted me to ,r~ travel by way of Chicago instead of Indianapolis. I believe this 

/ I was done by specifying a deviation through Chicago which can be 

J justified, 1f necessary, by the opportunity of seeing Albert or l \:all. 

~ Incidentally, I have received opin1ons only from ~ Corwith and McPherson 1n response to my request of March 24 con-

! cerning the SCAMP program. Have you received any replies? If not, 

r I suppose we should wait until the June meetings to get further J opinions although Miss Rees would undoubtedly have preferred to ~ . have them before that time. v~ Sincerely yours, 

s. s. Cairns 

Head of the Department 

c;ei. ,. 0 .4}-9 2 ---...,....,.---,,,,......,.----,___,,..,..,,.....,...-___,,,...,,.....,....,......,,..,,....,....,..-----=-...,,........,...,,.~ 

@'pproved for Release by NSA on 02-11-2014 pursuantto E.O. 1352a
**Exhibit 31.2**
**CERTIFICATION**
I, Christina W. Hagan, certify that:
 1.  I have reviewed this quarterly report on Form 10-Q of Dawson Geophysical Company;  2.  Based on my knowledge, this report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light ofthe circumstances under which such statements were made, not misleading with respect to theperiod covered by this report;  3.  Based on my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financial condition,results of operations and cash flows of the registrant as of, and for, the periodspresented in this report;  4.  The registrant’s other certifying officer and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) for the registrant and have:
 (a)  Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, ismade known to us by others within those entities, particularly during the period inwhich this report is being prepared;  (b)  Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by this reportbased on such evaluation; and  (c)  Disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter(the registrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting; and
 5.  The registrant’s other certifying officer and I have disclosed, based on our mostrecent evaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of the registrant’s board of directors (or personsperforming the equivalent functions):
 (a)  All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and report financialinformation; and  (b)  Any fraud, whether or not material, that involves management or other employeeswho have a significant role in the registrant’s internal control over financialreporting.
    Dated: May 12, 2005    /s/ Christina W. Hagan   Christina W. Hagan Executive Vice President, Secretary, Treasurer and Chief Financial Officer (principal financial and accounting officer)
```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 157 Introduced in Senate (IS)]

114th CONGRESS
  1st Session
                                 S. 157

   To repeal the medical device tax and the employer and individual 
 responsibility requirements of the Patient Protection and Affordable 
                               Care Act.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 13, 2015

  Mr. Cassidy introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
   To repeal the medical device tax and the employer and individual 
 responsibility requirements of the Patient Protection and Affordable 
                               Care Act.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``No Obamacare Mandate Act''.

SEC. 2. REPEAL OF MEDICAL DEVICE EXCISE TAX.

    (a) In General.--Chapter 32 of the Internal Revenue Code of 1986 is 
amended by striking subchapter E.
    (b) Conforming Amendments.--
            (1) Subsection (a) of section 4221 of the Internal Revenue 
        Code of 1986 is amended by striking the last sentence.
            (2) Paragraph (2) of section 6416(b) of such Code is 
        amended by striking the last sentence.
    (c) Clerical Amendment.--The table of subchapter for chapter 32 of 
the Internal Revenue Code of 1986 is amended by striking the item 
related to subchapter E.
    (d) Effective Date.--The amendments made by this section shall 
apply to sales after December 31, 2012.

SEC. 3. REPEAL OF INDIVIDUAL RESPONSIBILITY REQUIREMENT.

    Sections 1501 and 1502 and subsections (a), (b), (c), and (d) of 
section 10106 of the Patient Protection and Affordable Care Act (and 
the amendments made by such sections and subsections) are repealed and 
the Internal Revenue Code of 1986 shall be applied and administered as 
if such provisions and amendments had never been enacted.

SEC. 4. REPEAL OF EMPLOYER RESPONSIBILITY REQUIREMENT.

    Sections 1513 and 1514 and subsections (e), (f), and (g) of section 
10106 of the Patient Protection and Affordable Care Act (and the 
amendments made by such sections and subsections) are repealed and the 
Internal Revenue Code of 1986 shall be applied and administered as if 
such provisions and amendments had never been enacted.
                                 <all>
```
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   YEAR                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998             DEC-31-1997
<PERIOD-START>                             JAN-01-1998             JAN-01-1997
<PERIOD-END>                               DEC-31-1998             DEC-31-1997
<CASH>                                           1,562                   4,180
<SECURITIES>                                         0                       0
<RECEIVABLES>                                    5,918                   3,597
<ALLOWANCES>                                     (489)                   (180)
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                 7,340                   8,053
<PP&E>                                           3,475                   2,359
<DEPRECIATION>                                 (1,294)                   (820)
<TOTAL-ASSETS>                                  14,479                  14,573
<CURRENT-LIABILITIES>                            3,646                   2,856
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                            8,455                   8,440
<PREFERRED>                                          0                       0
<COMMON>                                             1                       1
<OTHER-SE>                                         580                   1,756
<TOTAL-LIABILITY-AND-EQUITY>                    14,479                  14,573
<SALES>                                         23,083                  18,307
<TOTAL-REVENUES>                                23,083                  18,307
<CGS>                                                0                       0
<TOTAL-COSTS>                                   23,764                  20,457
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                 179                     248
<INCOME-PRETAX>                                (1,007)                 (1,664)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                            (1,007)                 (1,664)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                        (155)                       0
<NET-INCOME>                                   (1,162)                 (1,664)
<EPS-PRIMARY>                                   (0.80)                  (1.07)
<EPS-DILUTED>                                   (0.40)                  (0.50)
        

</TABLE>
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          AUG-31-2000
<PERIOD-START>                             SEP-01-1999
<PERIOD-END>                               JUN-03-2000
<CASH>                                             534
<SECURITIES>                                         0
<RECEIVABLES>                                    6,377
<ALLOWANCES>                                         0
<INVENTORY>                                      4,663
<CURRENT-ASSETS>                                12,622
<PP&E>                                          21,395
<DEPRECIATION>                                  10,270
<TOTAL-ASSETS>                                  25,532
<CURRENT-LIABILITIES>                            8,509
<BONDS>                                          2,605
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           237
<OTHER-SE>                                      14,048
<TOTAL-LIABILITY-AND-EQUITY>                    25,532
<SALES>                                         29,075
<TOTAL-REVENUES>                                29,075
<CGS>                                           24,365
<TOTAL-COSTS>                                   24,365
<OTHER-EXPENSES>                                 6,504
<LOSS-PROVISION>                                    25
<INTEREST-EXPENSE>                                 180
<INCOME-PRETAX>                                (1,999)
<INCOME-TAX>                                     (385)
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,614)
<EPS-BASIC>                                      (.34)
<EPS-DILUTED>                                    (.34)


</TABLE>
• REF ID:A72050 

~-~~~ 

ENGINEERING RESEARCH ASSOCIATF.S, INC. 

507 Eighteenth Street, South 

.Arlington, Virginia 

Major General Ralph J. Canine, Director 

Anned Forces Security Agency 

Department of Defense 

Department of Defense 

Washington 25, D. c. 

Your Reference: Serial 0578 

Dear General Canine: 

7 October 1952' 

I appreciate your letter of 16 September 1952 enclosing the 

confidential report of Professor Cairns on the symposium last 

sununer at the Insti. tute for Numerical Analysis. I regret that 

I was unable to attend the symposiwn and obtain first-P,and 

knowledge of the work carried out there. However, both from 

reading Dr. Cairn• s report and from conversations wi. th individuals who were in attendance, I feel the symposium was well 

worth while am that the decision to continue the experiment 

another year is a wise one. 

With respect to the specific questi.ons you pose concerning the 

symposium, I submit the following replies which should be regarded as general opinions since I have not given the matter 

extensive study: 

1) The objectives of the program as stated in the memoraoium of Dr. Tompkins of 18 March should probably 

be revised. For example, I do not believe that the 

first objective "to proVi.de a convenient and attractive, 

but private, setting ••• " is really a primary motive 

for such a sympesium. 

2) The technical. progress during the past summer was, in 

my opinion, extremely good. Its direction appears to 

be about as close to the ideal for D'SA problems as 

could be achieved within the restr:i.ctions-of security. 

In my opinion, however, the work should be turned more 

closely to AFSA problems, if and when the security 

problems can be solved. 

peclassifi ed and approved for release by NSA on 02-12-2014 pursuantto E .0. 1352a 
... REF ID:A72050 

-~ 

Major General Ralph J. Canine -2- 1 Oc1D ber 19.52 

3) I believe that the same key people who participated 

this year should be sought for the next symposium 

to insure a continutiy of effort. In particular, it 

is important to retain the interests of such scientists 

as Professor s. s. Cairns, Professor John von Neumann, 

Professor H. P. Robertson, Dr. c. B. Tompkins. 

4) - Professor Cairns did an excellent job during the past 

summer am would make an excellent chairman for the 

next symposium. However,, there might be an advantage 

in vesting the chairmanship in AFSA personnel, in 

which case,, Dr. Kullback, Dr. Eachus or Dr. Campaigne 

would be excellent candidates. 

5) With respect to further objecti. ves, one which occurs 

at present is some sort of training function whereby 

young mathematicians could be steered into permanent 

AFSA positions. I will continue to think about this 

question and advise you on any conclusions. 

I am returning the confidential report of Professor Cairns herew.i.. th. I shall take advantage of your offer and read the appendices 

to the report when I am next at AFSA. 

HTE:nlb 

Enclosure: 

1 Cy "Report on SCAMP" 

dtd 8 Sep S2. 

Sincerely, 

/s/H. T. Engstrom 

H. T. Engstrom
<PAGE>

                                                                    EXHIBIT 99.2
PRESS RELEASE
-------------

CONTACTS:
Robert L. Baumgardner                    Mary Ellen Goodall
Little Switzerland, Inc.                 Walter Denby
340/776-2010                             D.F. King & Co., Inc.
                                         212/269-5550

FOR IMMEDIATE RELEASE
---------------------

                         LITTLE SWITZERLAND ANNOUNCES
                         ----------------------------
                    TRANSFER TO THE NASDAQ SMALLCAP MARKET
                    --------------------------------------

     ST. THOMAS, U.S. VIRGIN ISLANDS, November 11, 1999 . . . Little
Switzerland, Inc. (NASDAQ:LSVI) has been notified by The Nasdaq Stock Market,
Inc. ("NASDAQ") that its common stock will be transferred to The Nasdaq SmallCap
Market(SM) ("SmallCap") effective as of the open of business on Friday, November
12, 1999.  The Company's new trading symbol as of such date will be "LSVIC."

     The Company's president and chief executive officer, Robert Baumgardner,
stated "We are pleased with NASDAQ's decision to permit the Company's stock  to
be transferred to SmallCap.  We believe that continued listing on NASDAQ is
important to maintain liquidity for the Company's stockholders. "

     The Company's continued listing on SmallCap is subject to certain
conditions, including (i) obtaining asset-based financing to pay down its
existing debt and for working capital purposes and (ii) effecting a reverse
stock split which is subject to approval by the Company's stockholders at its
annual meeting which is currently scheduled for December 21, 1999. Although the
Company will work diligently towards meeting these conditions, there is no
assurance that it will be able to do so and that any actions proposed to be
taken by the Company to maintain its SmallCap listing will be effective.

     This press release contains forward-looking statements with respect to
certain events.  Forward-looking statements involve known and unknown risks,
uncertainties and other factors, which may cause the actual results, performance
or achievements of the Company to differ materially from anticipated future
results, performance or achievements expressed or implied by such forward-
looking statements.

     Little Switzerland, Inc. is a leading specialty retailer of brand name
watches, jewelry, crystal, china, fragrances and accessories, operating 20
stores on six Caribbean islands, and two stores in Alaska cruise ship
destinations.  The Company's primary market consists of vacationing tourists
attracted by free-port pricing, duty-free allowances and a wide variety of high
quality merchandise.
                                     # # #
<PAGE>

                                                                   Exhibit 23.08



                       CONSENT OF INDEPENDENT ACCOUNTANTS


We hereby consent to the use in the Prospectus constituting part of this
Registration Statement on Form S-4 of our report dated February 18, 1998,
relating to the financial statements of Regency Electric Company, Inc. and
subsidiaries which appears in such Prospectus.



                                         /s/ Harbeson, Beckerleg & Fletcher
                                         ---------------------------------------
                                             Harbeson, Beckerleg & Fletcher



Harbeson, Beckerleg & Fletcher
Jacksonville, Florida
June 23, 1999
##### 



EXHIBIT 32.1
 CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
  1.
    
    The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
 2.
    
    The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
 /s/ Gerhard F. BurbachGerhard F. BurbachChief Executive OfficerDate: November  9, 2006
  41